Ovarian cancer survivors may experience Quality of Life (QOL) disruptions due to the aggressiveness of the illness and its treatment. The present manuscript intends to review the most recent knowledge regarding QOL in ovarian cancer survivors. Firstly, a brief overview about QOL, their importance and instruments used to assess it particularly in ovarian cancer survivors are presented. Then, main findings and developments achieved to date are discussed. Main conclusions from studies reviewed and future research needs are outlined. Available literature suggests that in general ovarian cancer survivors experience a good QOL; however, some deficits are more prevalent than in women without cancer. Although, these studies brought to light ...
Background: While many cancer survivors experience persistent impairments in health-related quality ...
OBJECTIVE: In this study, we evaluated the effect of body mass index (BMI) on the quality of life of...
INTRODUCTION: In the last two decades, the therapeutic outcomes of ovarian germ cell Tumor patient...
Despite growing interest in quality of life (QOL) ar an important variable in nursing and health car...
PURPOSE:Long-term survival of women with advanced-stage ovarian cancer is relatively rare. Little is...
It was estimated that in 2009,21,550 women would be diagnosed with ovarian cancer and 14.600 women w...
Simple Summary: The aim of this analysis was to evaluate the health-related quality of life (HR-QoL)...
There is no consensus as to what symptoms or quality-of-life (QOL) domains should be measured as pat...
Background: There is wide variation in the application of adjuvant chemotherapy in early-stage epit...
Objectives: Our aim was to investigate the prevalence and potential risk factors for persistent and ...
OBJECTIVE: Although advanced stage epithelial ovarian cancer is widely considered life-threatening, ...
BACKROUND: The number of cancer survivors is growing steadily and increasingly, clinical trials are ...
Formal quality-of-life (QOL) assessments may contribute important information on patient symptoms. D...
Backround: The number of cancer survivors is growing steadily and increasingly, clinical trials are ...
Objective To assess the association between gastro-intestinal (GI) symptoms and health-related quali...
Background: While many cancer survivors experience persistent impairments in health-related quality ...
OBJECTIVE: In this study, we evaluated the effect of body mass index (BMI) on the quality of life of...
INTRODUCTION: In the last two decades, the therapeutic outcomes of ovarian germ cell Tumor patient...
Despite growing interest in quality of life (QOL) ar an important variable in nursing and health car...
PURPOSE:Long-term survival of women with advanced-stage ovarian cancer is relatively rare. Little is...
It was estimated that in 2009,21,550 women would be diagnosed with ovarian cancer and 14.600 women w...
Simple Summary: The aim of this analysis was to evaluate the health-related quality of life (HR-QoL)...
There is no consensus as to what symptoms or quality-of-life (QOL) domains should be measured as pat...
Background: There is wide variation in the application of adjuvant chemotherapy in early-stage epit...
Objectives: Our aim was to investigate the prevalence and potential risk factors for persistent and ...
OBJECTIVE: Although advanced stage epithelial ovarian cancer is widely considered life-threatening, ...
BACKROUND: The number of cancer survivors is growing steadily and increasingly, clinical trials are ...
Formal quality-of-life (QOL) assessments may contribute important information on patient symptoms. D...
Backround: The number of cancer survivors is growing steadily and increasingly, clinical trials are ...
Objective To assess the association between gastro-intestinal (GI) symptoms and health-related quali...
Background: While many cancer survivors experience persistent impairments in health-related quality ...
OBJECTIVE: In this study, we evaluated the effect of body mass index (BMI) on the quality of life of...
INTRODUCTION: In the last two decades, the therapeutic outcomes of ovarian germ cell Tumor patient...